Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

40.10
Delayed Data
As of May 22
 -0.43 / -1.06%
Today’s Change
30.13
Today|||52-Week Range
52.58
-21.14%
Year-to-Date

Today’s Trading

Previous close40.53
Today’s open40.37
Day’s range39.79 - 40.68
Volume230,362
Average volume (3 months)318,551
Market cap$757.6M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+190.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+48.94%
P/E ratio6.8
Price/Sales19.55
Price/Book5.07

Competitors

 Today’s
change
Today’s
% change
TKMRTekmira Pharmaceutic...-0.24-1.73%
OTICOtonomy Inc-6.19-19.94%
EPZMEpizyme Inc+0.10+0.53%
SGNTSagent Pharmaceutica...-0.02-0.09%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.30
Annual revenue (last year)$47.7M
Annual profit (last year)$34.4M
Net profit margin72.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
Chief Financial Officer &
Senior VP-Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers